| | | | | | | | | | |
| | |
 | Issue Date FY: 2021 ( Subtotal = $5,519,177 ) (Continued on the next page) |
| | 2021 | 2021 | K01DK113067 | Coordinate roles of histone H3K27me3 and DNA methylation in intestinal homeostasis and tumorigenesis | 000 | 5 | NIH | 11/24/2020 | 072933393 | $155,304 |
| | 2021 | 2021 | R01ES030364 | Effects of DDE exposure on adipose tissue function, weight loss and metabolic improvement after bariatric surgery: A new paradigm for study of lipophilic chemicals | 000 | 2 | NIH | 11/19/2020 | 072933393 | $638,117 |
| | 2021 | 2021 | R01DC017741 | Mechanisms of cochlear synaptopathy after noise or blast trauma | 000 | 2 | NIH | 11/20/2020 | 072933393 | $606,342 |
| | 2021 | 2021 | R01DA046049 | Cannabis use and health outcomes among opioid-using people who inject drugs in the context of cannabis legalization | 001 | 3 | NIH | 11/4/2020 | 072933393 | $71,951 |
| | 2021 | 2021 | R01DA046049 | Cannabis use and health outcomes among opioid-using people who inject drugs in the context of cannabis legalization | 000 | 3 | NIH | 11/3/2020 | 072933393 | $524,865 |
| | 2021 | 2021 | R01AI135122 | Small Molecule Inhibitors Targeting Adenovirus | 000 | 3 | NIH | 11/24/2020 | 072933393 | $617,449 |
| | 2021 | 2021 | R03MH125253 | Socioeconomic Heterogeneity in the Impact of Psychiatric Care: A Secondary Analysis of the RAISE-ETP Trial for Patients with First-Episode Psychosis | 000 | 1 | NIH | 11/19/2020 | 072933393 | $82,500 |
| | 2021 | 2021 | R03CA245998 | Exploring the shared genetic architecture of white blood cell variation and childhood acute lymphoblastic leukemia | 000 | 2 | NIH | 11/20/2020 | 072933393 | $81,744 |
| | 2021 | 2021 | R01DC018562 | Roles for Glucosensors in Taste Function | 000 | 1 | NIH | 11/4/2020 | 072933393 | $432,083 |
| | 2021 | 2021 | 09CH011831 | Head Start and Early Head Start | 00 | 1 | ACF | 10/22/2020 | 072933393 | $19,119 |
| | 2021 | 2021 | 09CH011831 | Head Start and Early Head Start | 00 | 1 | ACF | 10/22/2020 | 072933393 | $22,830 |
| | 2021 | 2021 | 09CH011831 | Head Start and Early Head Start | 00 | 1 | ACF | 10/22/2020 | 072933393 | $3,207,386 |
| | 2021 | 2020 | UL1TR001855 | Southern California Clinical and Translational Institute | 000 | 5 | NIH | 11/14/2020 | 072933393 | $0 |
| | 2021 | 2020 | R35CA200422 | Molecular Basis of KSHV oncogenesis | 000 | 5 | NIH | 11/4/2020 | 072933393 | -$610,219 |
| | 2021 | 2020 | 09CH010228 | Head Start and Early Head Start | 04 | 5 | ACF | 11/6/2020 | 072933393 | $0 |
| | 2021 | 2020 | 09CH010228 | Head Start and Early Head Start | 04 | 5 | ACF | 11/6/2020 | 072933393 | $0 |
| | 2021 | 2020 | 09CH010228 | Head Start and Early Head Start | 04 | 5 | ACF | 11/6/2020 | 072933393 | $0 |
| | 2021 | 2020 | 09CH010228 | Head Start and Early Head Start | 04 | 5 | ACF | 11/6/2020 | 072933393 | $0 |
| | 2021 | 2020 | R01DE023926 | KSHV Epigenetic Regulation | 000 | 6 | NIH | 10/28/2020 | 072933393 | -$332,013 |
| | 2021 | 2020 | T32DC009975 | Training in Hearing and Communication Neuroscience | 001 | 11 | NIH | 11/24/2020 | 072933393 | $27,517 |
| | 2021 | 2020 | R01CA101795 | NOVEL STRATEGIES FOR INTERVENTION OF INFLAMMATORY DISEASES AND CANCER | 000 | 13 | NIH | 11/9/2020 | 072933393 | $297,644 |
| | 2021 | 2020 | R01CA101795 | NOVEL STRATEGIES FOR INTERVENTION OF INFLAMMATORY DISEASES AND CANCER | 000 | 13 | NIH | 11/9/2020 | 072933393 | $403,677 |
| | 2021 | 2020 | R01CA101795 | NOVEL STRATEGIES FOR INTERVENTION OF INFLAMMATORY DISEASES AND CANCER | 000 | 13 | NIH | 11/9/2020 | 072933393 | $129,260 |
| | 2021 | 2020 | U01AG068057 | Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease Biobanks | 000 | 1 | NIH | 11/4/2020 | 072933393 | $0 |
| | 2021 | 2020 | R21EB030244 | MRI-Controllable Microscale Electronics for Minimally-Invasive Wireless Bio-Sensors and Bio-Actuators | 000 | 1 | NIH | 11/16/2020 | 072933393 | $0 |
| | 2021 | 2020 | R37AR060306 | Tissue Patterning in living skin and organ ex | 000 | 11 | NIH | 10/13/2020 | 072933393 | $288,270 |
| | 2021 | 2020 | P30AG066530 | Alzheimer Disease Research Center | 000 | 1 | NIH | 10/19/2020 | 072933393 | $0 |
| | 2021 | 2020 | P50MD015705 | Maternal and Developmental Risks from Environmental and Social Stressors (MADRES) | 000 | 6 | NIH | 10/20/2020 | 072933393 | $300,000 |
| | 2021 | 2020 | P50MD015705 | Maternal and Developmental Risks from Environmental and Social Stressors (MADRES) | 000 | 6 | NIH | 10/20/2020 | 072933393 | $207,924 |
| | 2021 | 2020 | K08EY031797 | In vivo Application of Electrical Fields Directs Retinal Ganglion Cell Axon Regeneration | 000 | 1 | NIH | 11/23/2020 | 072933393 | $0 |
| | 2021 | 2020 | R00HG010160 | From common to rare variant functional architectures of human diseases | 000 | 3 | NIH | 11/12/2020 | 072933393 | $1,739 |
| | 2021 | 2020 | K99DE028573 | Molecular regulatory mechanism of Zika virus-induced intracranial calcifications | 000 | 1 | NIH | 10/28/2020 | 072933393 | -$47,021 |
| | 2021 | 2020 | K99DE028573 | Molecular regulatory mechanism of Zika virus-induced intracranial calcifications | 000 | 1 | NIH | 10/28/2020 | 072933393 | -$47,021 |
| | 2021 | 2020 | R36DA048343 | An Examination of the Effects of Synthetic Opioids on Injecting Heroin Trajectories, Practices, and Risk Behaviors | 000 | 1 | NIH | 11/18/2020 | 072933393 | $0 |
| | 2021 | 2020 | R61AG066543 | Clinical trials to prevent Alzheimer's Disease in Down Syndrome | 000 | 2 | NIH | 10/15/2020 | 072933393 | $0 |
| | 2021 | 2020 | R61AG066543 | Clinical trials to prevent Alzheimer's Disease in Down Syndrome | 000 | 2 | NIH | 10/15/2020 | 072933393 | $0 |
| | 2021 | 2020 | R21DA049572 | UTILIZING TWITTER TO IDENTIFY AND RECRUIT YOUNG BLACK MEN AT HIGH RISK OF HIV INFECTION | 001 | 2 | NIH | 11/3/2020 | 072933393 | $72,289 |
| | 2021 | 2020 | R21HD096521 | Wearable Sensors for Early Identification of Poor Neurodevelopment in Guatemala | 000 | 2 | NIH | 11/10/2020 | 072933393 | -$159,032 |
| | 2021 | 2020 | R21HD096521 | Wearable Sensors for Early Identification of Poor Neurodevelopment in Guatemala | 000 | 2 | NIH | 11/10/2020 | 072933393 | -$5,000 |
| | 2021 | 2020 | U1Q28740 | Geriatrics Workforce Enhancement Program | 01 | 5 | HRSA | 11/20/2020 | 072933393 | $0 |
| | 2021 | 2020 | U1Q28740 | Geriatrics Workforce Enhancement Program | 01 | 5 | HRSA | 11/20/2020 | 072933393 | $0 |
| | 2021 | 2020 | R21DE028256 | Targeting the host NDP kinase to abrogate viral dissemination | 000 | 2 | NIH | 11/9/2020 | 072933393 | -$122,910 |
| | 2021 | 2020 | R01DE028521 | KSHVmediated regulation of proline metabolism | 000 | 2 | NIH | 10/28/2020 | 072933393 | -$193,116 |
| | 2021 | 2020 | R01ES029092 | Molecular Mechanism of UV Protection in Cutaneous Melanoma | 000 | 2 | NIH | 10/29/2020 | 072933393 | -$439,675 |
| | 2021 | 2020 | 90PPHM0001 | Promoting Aging in Place by Enhancing Access to Home Modifications | 01 | 3 | ACL | 11/10/2020 | 072933393 | $0 |
| | 2021 | 2020 | R34AA025968 | Mobile Application Intervention Targeting the High Risk Drinking Practice of Prepartying | 001 | 3 | NIH | 11/5/2020 | 072933393 | $193,261 |
| | 2021 | 2020 | 90ABRC0001 | National Center on Elder Abuse (NCEA) at the Keck School of Medicine of USC | 01 | 4 | ACL | 11/12/2020 | 072933393 | $0 |
| | 2021 | 2020 | 90ABRC0001 | National Center on Elder Abuse (NCEA) at the Keck School of Medicine of USC | 01 | 4 | ACL | 11/12/2020 | 072933393 | $0 |
| | 2021 | 2020 | R01AG053798 | Global Alzheimer's Platform Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease | 000 | 3 | NIH | 10/15/2020 | 072933393 | $0 |
|
